Kakali Hossain

Kakali Hossain is a Clinical Research Associate at Aimmune Therapeutics since September 2017, contributing to the FDA approval of Palforzia and supporting global studies in collaboration with regulatory processes in the US and Europe. Previously, Kakali held multiple roles at Acerta Pharma B.V., providing comprehensive support in clinical trial management, including monitoring adherence to protocols and managing regulatory documentation. At Genentech, logistical support was provided across oncology-focused clinical trials, while at West Coast Research LLC and Stanford University Hospital, Kakali coordinated clinical research activities, patient recruitment, and adherence to regulatory guidelines, emphasizing Good Clinical Practice throughout. Educational qualifications include degrees from the University of California, Santa Cruz, and Mymensingh Medical College, Bangladesh.